Robert C. Bollinger, MD, MPH

CRS:

BJMC

Role:

Investigators

Position:

Professor of Medicine Director, CCGHE Associate Director, Center for Global Health

Email:

rcb@jhmi.edu

Robert C. Bollinger is a Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine, with joint appointments in International Health at the Johns Hopkins (JH) Bloomberg School of Public Health and in Community Public Health at the JH School of Nursing.  He is the founding Director of the JH Center for Clinical Global Health Education (CCGHE) and the Associate Director for Medicine of the JH Center for Global Health, which coordinates all JHU global health activities.  He also directs the JHU Fogarty India Program, which provides training to Indian scientists, and the Global Health Course for JH medical students, which uses videoconference technology to link medical students and faculty around the globe. 
 
Dr. Bollinger has more than 30 years of experience in international public health, clinical research, and education in a broad range of global health priorities including HIV/AIDS, malaria, tuberculosis, leprosy, and emerging infections.  He has published more than 140 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision. In addition, his commitment to clinician education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award. Now working with partners in more than 20 countries, Dr. Bollinger and the CCGHE faculty are pioneers and global leaders in the development and use of distance learning and their award-winning mobile Health platform (emocha®) in resource-limited settings (http://emocha.org/). An esteemed global health expert, Dr. Bollinger has contributed to public health training programs, expert committees, and consultations in over 15 countries. He has also been a member of the US Presidential Advisory Council for HIV/AIDS (PACHA), where he served as a member of the PACHA International Sub-committee.  
 
Dr. Bollinger's research interests include identification of biological and behavioral risk factors for HIV transmission; characterization of the clinical progression and treatment of HIV and related infections; and implementation science research projects to optimize health care capacity and care delivery in resource-limited settings through task-shifting, clinical education, distance learning and mobile Health. Dr. Bollinger is actively engaged in collaborative research projects in Colombia, Uganda, and the US and his engagement in India has spanned more than three decades.  In 1992, he initiated an ongoing, NIH-funded Indo-US HIV research program in Pune involving the National AIDS Research Institute/ICMR and the BJ Medical College.  He has also been the Principal Investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which changed World Health Organization (WHO) guidelines. Under Dr. Bollinger’s leadership, the Hopkins Fogarty International Program has provided short-term and degree training to more than 100 visiting scientists at JHU and in-country training to more than 2000 Indian scientists since 1992 (see information about 2013 Training Award).  Under his directorship, ongoing CCGHE programs were initiated in India and are expanding. Recently, Dr. Bollinger was selected to direct the newly formed IMEC-JHU Partnership to advance applications in health care. The collaboration will combine JH clinical and research expertise with IMEC nanoelectronic capabilities (read more).

Dr. Bollinger received an undergraduate degree from Haverford College, a Doctor of Medicine from Dartmouth Medical School, and a Masters in Public Health from JH Bloomberg School of Public Health. He completed his Internal Medicine training at the University of Maryland Medical Systems followed by a post-doctoral fellowship in Infectious Diseases at JHU School of Medicine.  Dr. Bollinger is Board Certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine.

.

.

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More

A5329: Interferon –Free Therapy for Chronic Hepatitis C...

A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

A5342: Evaluating the Safety, Tolerability, and Effect of a...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

Read More